47
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Circulating antibodies to cysteinyl catecholamines in amyotrophic lateral sclerosis and Parkinson's disease patients

, , , &
Pages 226-233 | Received 08 Mar 2005, Accepted 04 Jun 2005, Published online: 10 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Charles Nicaise, Jerome Coupier, Marie‐Pierre Dabadie, Robert De Decker, Arturo Mangas, Dominique Bodet, Luc Poncelet, Michel Geffard & Roland Pochet. (2008) Gemals, a new drug candidate, extends lifespan and improves electromyographic parameters in a rat model of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 9:2, pages 85-90.
Read now

Articles from other publishers (10)

Isidro Badillo-Ramírez, Bruno Landeros-Rivera, José M. Saniger, Jürgen Popp & Dana Cialla-May. (2023) SERS-based detection of 5- S -cysteinyl-dopamine as a novel biomarker of Parkinson's disease in artificial biofluids . The Analyst 148:8, pages 1848-1857.
Crossref
Ali Taghizadeh, Mohsen Taghizadeh, Mohsen Khodadadi Yazdi, Payam Zarrintaj, Joshua D. Ramsey, Farzad Seidi, Florian J. Stadler, Haeshin Lee, Mohammad Reza Saeb & Masoud Mozafari. (2022) Mussel‐inspired biomaterials: From chemistry to clinic. Bioengineering & Translational Medicine 7:3.
Crossref
Isidro Badillo-Ramírez, José M. Saniger & Selva Rivas-Arancibia. (2019) 5-S-cysteinyl-dopamine, a neurotoxic endogenous metabolite of dopamine: Implications for Parkinson's disease. Neurochemistry International 129, pages 104514.
Crossref
Gonçalves-Dias, Morello, Semedo, Correia, Coelho, Monteiro, Antunes & Pereira. (2019) The mercapturomic profile of health and non-communicable diseases. High-Throughput 8:2, pages 10.
Crossref
Cristina Aureli, Tommaso Cassano, Alessandra Masci, Antonio Francioso, Sara Martire, Annalisa Cocciolo, Silvia Chichiarelli, Adele Romano, Silvana Gaetani, Patrizia Mancini, Mario Fontana, Maria d'Erme & Luciana Mosca. (2014) 5-S-cysteinyldopamine neurotoxicity: Influence on the expression of α-synuclein and ERp57 in cellular and animal models of Parkinson's disease. Journal of Neuroscience Research 92:3, pages 347-358.
Crossref
Saliha Aït-Aïssa, Bernard Billaudel, Florence Poulletier de Gannes, Gilles Ruffié, Sébastien Duleu, Annabelle Hurtier, Emmanuelle Haro, Murielle Taxile, Axel Athané, Michel Geffard, Tongning Wu, Joe Wiart, Dominique Bodet, Bernard Veyret & Isabelle Lagroye. (2012) In utero and early-life exposure of rats to a Wi-Fi signal: Screening of immune markers in sera and gestational outcome. Bioelectromagnetics 33:5, pages 410-420.
Crossref
F. Poulletier de Gannes, M. Taxile, S. Duleu, A. Hurtier, E. Haro, M. Geffard, G. Ruffié, B. Billaudel, P. Lévêque, P. Dufour, I. Lagroye & B. Veyret. (2009) A Confirmation Study of Russian and Ukrainian Data on Effects of 2450 MHz Microwave Exposure on Immunological Processes and Teratology in Rats. Radiation Research 172:5, pages 617.
Crossref
Olivier Pouns, Arturo Mangas, Rafael Coveñas & Michel Geffard. (2009) Circulating antibodies directed against “polycyclic aromatic hydrocarbon-like” structures in the sera of cancer patients. Cancer Epidemiology 33:1, pages 3-8.
Crossref
Luciana Mosca, Italo Tempera, Eugenio Lendaro, Laura Di Francesco & Maria d'Erme. (2008) Characterization of catechol-thioether-induced apoptosis in human SH-SY5Y neuroblastoma cells. Journal of Neuroscience Research 86:4, pages 954-960.
Crossref
Renata Silva, Sílvia Boldt, Vera Marisa Costa, Helena Carmo, Márcia Carvalho, Félix Carvalho, Maria de Lourdes Bastos, Francisco Lemos‐Amado & Fernando Remião. (2007) Evaluation of GSH adducts of adrenaline in biological samples. Biomedical Chromatography 21:7, pages 670-679.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.